[LGND] QoQ Quarter Result on 30-Jun-2010 [#Q2]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
05-Aug-2010
Financial Year
2010
Quarter
30-Jun-2010 [#Q2]
Profit Trend
QoQ- 89.71%
YoY- 83.03%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 CAGR
Revenue 3,896 3,940 7,802 5,838 5,958 13,977 7,901 -37.61%
PBT -4,292 -1,587 -11,436 335 -2,715 1,034 1,055 -
Tax -13,778 -3,935 419 625 274 -1,535 -748 598.70%
NP 9,625 4,503 -11,843 -283 -2,750 3,036 1,803 205.75%
Tax Rate - - - -186.57% - 148.45% 70.90% -
Total Cost -5,729 -563 19,645 6,121 8,708 10,941 6,098 -
Ratio Analysis
31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 CAGR
NP Margin 247.05 114.29 -151.79 -4.85 -46.16 21.72 22.82 390.09%
Per Share
31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 CAGR
EPS 0.49 0.23 -0.60 -0.01 -0.14 0.16 0.12 155.69%
EPS Diluted 0.49 0.23 -0.60 -0.01 -0.14 0.16 0.12 155.69%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.